On the public citation graph

AI-Driven Drug Discovery: A Comprehensive Review

0 signed · 257 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1521-3838(200110)20:3<227::aid-qsar227>3.0.co;2-yopenalex-snapshot
Use of Support Vector Machine in Pattern Classification: Application to QSAR Studies
inferredcites →https://doi.org/10.1002/alz.13479openalex-snapshot
Artificial intelligence for neurodegenerative experimental models
inferredcites →https://doi.org/10.1002/jmv.28693openalex-snapshot
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
inferredcites →https://doi.org/10.1002/med.21764openalex-snapshot
Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions
inferredcites →https://doi.org/10.1002/minf.202100113openalex-snapshot
ADMET Predictability at Boehringer Ingelheim: State‐of‐the‐Art, and Do Bigger Datasets or Algorithms Make a Difference?
inferredcites →https://doi.org/10.1007/s10822-014-9747-xopenalex-snapshot
FreeSolv: a database of experimental and calculated hydration free energies, with input files
inferredcites →https://doi.org/10.1007/s41781-023-00105-wopenalex-snapshot
Photon Reconstruction in the Belle II Calorimeter Using Graph Neural Networks
inferredcites →https://doi.org/10.1016/j.ailsci.2022.100036openalex-snapshot
Understanding the performance of knowledge graph embeddings in drug discovery
inferredcites →https://doi.org/10.1016/j.clinthera.2019.05.018openalex-snapshot
A Study on the Application and Use of Artificial Intelligence to Support Drug Development
inferredcites →https://doi.org/10.1016/j.isci.2020.101961openalex-snapshot
Pushing the limits of solubility prediction via quality-oriented data selection
inferredcites →https://doi.org/10.1016/j.jiph.2022.01.011openalex-snapshot
Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery
inferredcites →https://doi.org/10.1016/s0097-8485(01)00094-8openalex-snapshot
Drug design by machine learning: support vector machines for pharmaceutical data analysis
inferredcites →https://doi.org/10.1021/acs.jcim.0c00155openalex-snapshot
LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening
inferredcites →https://doi.org/10.1021/acs.jcim.1c00683openalex-snapshot
Machine Learning Models Identify Inhibitors of SARS-CoV-2
inferredcites →https://doi.org/10.1021/acs.jcim.1c01334openalex-snapshot
DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design
inferredcites →https://doi.org/10.1021/acs.jcim.2c01569openalex-snapshot
MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning
inferredcites →https://doi.org/10.1021/acs.jctc.4c01091openalex-snapshot
Large-Scale Parameter Estimation for Crystal Structure Prediction. Part 1: Dataset, Methodology, and Implementation
inferredcites →https://doi.org/10.1021/acs.jpclett.4c01509openalex-snapshot
Efficient Deep Model Ensemble Framework for Drug-Target Interaction Prediction
inferredcites →https://doi.org/10.1021/ci034160gopenalex-snapshot
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
inferredcites →https://doi.org/10.1021/ci034243xopenalex-snapshot
ESOL: Estimating Aqueous Solubility Directly from Molecular Structure
inferredcites →https://doi.org/10.1038/aps.2012.109openalex-snapshot
Computational drug discovery
inferredcites →https://doi.org/10.1038/s41467-021-27137-3openalex-snapshot
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system
inferredcites →https://doi.org/10.1038/s41467-023-39120-1openalex-snapshot
Discovery of senolytics using machine learning
inferredcites →https://doi.org/10.1038/s41467-024-45566-8openalex-snapshot
Transfer learning with graph neural networks for improved molecular property prediction in the multi-fidelity setting
inferredcites →https://doi.org/10.1038/s41467-025-60252-zopenalex-snapshot
An end-to-end attention-based approach for learning on graphs
inferredcites →https://doi.org/10.1038/s41597-022-01390-7openalex-snapshot
QMugs, quantum mechanical properties of drug-like molecules
inferredcites →https://doi.org/10.1038/s41598-020-62848-5openalex-snapshot
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
inferredcites →https://doi.org/10.1038/s41598-024-56706-xopenalex-snapshot
Evaluation metrics and statistical tests for machine learning
inferredcites →https://doi.org/10.1039/c7sc02664aopenalex-snapshot
MoleculeNet: a benchmark for molecular machine learning
inferredcites →https://doi.org/10.1093/bib/bbaa044openalex-snapshot
Identifying drug–target interactions based on graph convolutional network and deep neural network
inferredcites →https://doi.org/10.1093/bib/bbac109openalex-snapshot
DTI-HETA: prediction of drug–target interactions based on GCN and GAT on heterogeneous graph
inferredcites →https://doi.org/10.1093/bib/bbad483openalex-snapshot
Joint deep autoencoder and subgraph augmentation for inferring microbial responses to drugs
inferredcites →https://doi.org/10.1093/brain/awz384openalex-snapshot
A multiomics approach to heterogeneity in Alzheimer’s disease: focused review and roadmap
inferredcites →https://doi.org/10.1101/2024.03.22.586314openalex-snapshot
ChemPrint: An AI-Driven Framework for Enhanced Drug Discovery
inferredcites →https://doi.org/10.1109/access.2024.3373195openalex-snapshot
Explainable Artificial Intelligence for Drug Discovery and Development: A Comprehensive Survey
inferredcites →https://doi.org/10.1109/bibm62325.2024.10822084openalex-snapshot
Predicting Distant Drug-Target Interactions via a Random Walk Guided Graph Neural Network
inferredcites →https://doi.org/10.1109/ictai50040.2020.00060openalex-snapshot
DTIGCCN: Prediction of drug-target interactions based on GCN and CNN
inferredcites →https://doi.org/10.1109/tcbb.2023.3339645openalex-snapshot
SMGCN: Multiple Similarity and Multiple Kernel Fusion Based Graph Convolutional Neural Network for Drug-Target Interactions Prediction
inferredcites →https://doi.org/10.1145/3770854.3785701openalex-snapshot
Benchmarking Positional Encodings for GNNs and Graph Transformers
inferredcites →https://doi.org/10.1155/2021/7181815openalex-snapshot
Mol‐BERT: An Effective Molecular Representation with BERT for Molecular Property Prediction
inferredcites →https://doi.org/10.1177/17411343221151109openalex-snapshot
An empirical study to accelerate machine learning and artificial intelligence adoption in pharmaceutical manufacturing organizations
inferredcites →https://doi.org/10.1186/s12915-024-02028-3openalex-snapshot
DrugReAlign: a multisource prompt framework for drug repurposing based on large language models
inferredcites →https://doi.org/10.14573/altex.2309191openalex-snapshot
ToxAIcology - The evolving role of artificial intelligence in advancing toxicology and modernizing regulatory science
inferredcites →https://doi.org/10.1530/jme-18-0055openalex-snapshot
Integrated omics: tools, advances and future approaches
inferredcites →https://doi.org/10.22214/ijraset.2024.58430openalex-snapshot
Decoding Tomorrows Biotechnology: AI and Machine Learning Unveiled
inferredcites →https://doi.org/10.30574/wjarr.2024.21.2.0460openalex-snapshot
The role of AI in transforming auditing practices: A global perspective review
inferredcites →https://doi.org/10.33696/pharmacol.4.043openalex-snapshot
From Data to Knowledge: A Mini-Review on Molecular Network Modeling and Analysis for Therapeutic Target Discovery
inferredcites →https://doi.org/10.3389/fddsv.2022.1019706openalex-snapshot
How artificial intelligence enables modeling and simulation of biological networks to accelerate drug discovery
inferredcites →https://doi.org/10.3389/fmolb.2021.628144openalex-snapshot
Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection
inferredcites →https://doi.org/10.3389/fphar.2024.1393415openalex-snapshot
Knowledge mapping of graph neural networks for drug discovery: a bibliometric and visualized analysis
inferredcites →https://doi.org/10.3389/frai.2023.1334613openalex-snapshot
Explaining graph convolutional network predictions for clinicians—An explainable AI approach to Alzheimer's disease classification
inferredcites →https://doi.org/10.3390/cells10113139openalex-snapshot
Evaluation of the Effectiveness of Herbal Components Based on Their Regulatory Signature on Carcinogenic Cancer Cells
inferredcites →https://doi.org/10.3390/cells8050470openalex-snapshot
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
inferredcites →https://doi.org/10.3390/ddc3010009openalex-snapshot
Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications
inferredcites →https://doi.org/10.3390/genes10030238openalex-snapshot
Challenges in the Integration of Omics and Non-Omics Data
inferredcites →https://doi.org/10.3390/ijms21103585openalex-snapshot
Similarity-Based Methods and Machine Learning Approaches for Target Prediction in Early Drug Discovery: Performance and Scope
inferredcites →https://doi.org/10.3390/ijms232113568openalex-snapshot
Application of Computational Biology and Artificial Intelligence in Drug Design
inferredcites →https://doi.org/10.3390/ijms24098326openalex-snapshot
MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction
inferredcites →https://doi.org/10.3390/pharmaceutics15071916openalex-snapshot
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
inferredcites →https://doi.org/10.38124//ijisrt/ijisrt24aug1084openalex-snapshot
Molecular Classification with Graph Convolutional Networks: Exploring the MUTAG Dataset for Mutagenicity Prediction
inferredcites →https://doi.org/10.52202/085713openalex-snapshot
Advances in Neural Information Processing Systems 19
inferredcites →https://doi.org/10.5772/intechopen.88376openalex-snapshot
Artificial Intelligence in Oncology Drug Discovery and Development
inferredcites →https://doi.org/10.5772/intechopen.95698openalex-snapshot
Density Functional Theory - Recent Advances, New Perspectives and Applications
inferredcites →https://doi.org/10.60087/jklst.vol2.n3.p391openalex-snapshot
From Data to Compliance: The Role of AI/ML in Optimizing Regulatory Reporting Processes

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/aff2.70259openalex-snapshot
Decoding Aquaculture's Future: A Review of Molecular Docking and Simulation in Enhancing Growth and Disease Resistance
inferred← citeshttps://doi.org/10.1002/bit.70398openalex-snapshot
From Sequence to Structure: AlphaFold and the AI Revolution in Aquaculture Drug Discovery and Vaccine Design
inferred← citeshttps://doi.org/10.1002/cmdc.70304openalex-snapshot
India's Drug Discovery and Development Industry: The Quest for Novel Therapeutic Treatments
inferred← citeshttps://doi.org/10.1002/cmdc.70362openalex-snapshot
Integrative Molecular Scaffold Generation of PI3K/mTOR Inhibitors Using DeepSARM and Ligand‐Based Virtual Screening Approaches
inferred← citeshttps://doi.org/10.1002/cmdc.70441openalex-snapshot
Medicinal and Crop Protection Chemistry: Breaking Barriers, Building Synergies
inferred← citeshttps://doi.org/10.1002/ddr.70281openalex-snapshot
Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical Innovation
inferred← citeshttps://doi.org/10.1002/psc.70063openalex-snapshot
In Silico Peptide Design: Methods, Resources, and Role of AI
inferred← citeshttps://doi.org/10.1002/slct.202507418openalex-snapshot
Drug Discovery and Computational Chemistry: A State‐of‐the‐Art Review
inferred← citeshttps://doi.org/10.1002/slct.74164openalex-snapshot
FtsZ‐LSTM: Generative AI Model for AntiBacterial Hits Discovery
inferred← citeshttps://doi.org/10.1002/slct.74240openalex-snapshot
The Evolution of Generative Chemistry in Medicinal Chemistry
inferred← citeshttps://doi.org/10.1002/slct.74689openalex-snapshot
A Comprehensive Review on Cu(II) Complexes With Pyrazine or Pyrazine Derivatives: Synthesis, Characterization, Crystal Engineering, Magnetic, and Biological Applications
inferred← citeshttps://doi.org/10.1007/978-1-0716-5408-8_4openalex-snapshot
Scaling Biomedical Text-Mining: Transformers, GenAI, and Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-3-032-10277-5_1openalex-snapshot
Introduction to Artificial Intelligence in Pharmaceutical Sciences
inferred← citeshttps://doi.org/10.1007/978-3-032-10277-5_5openalex-snapshot
AI Drug Repurposing and Personalized Medicine
inferred← citeshttps://doi.org/10.1007/978-3-032-10277-5_7openalex-snapshot
Future Trends and Innovations in AI-Driven Drug Development
inferred← citeshttps://doi.org/10.1007/978-3-032-20428-8_1openalex-snapshot
Fundamentals of Generative AI in Drug Development
inferred← citeshttps://doi.org/10.1007/978-3-032-20428-8_11openalex-snapshot
Trends of Open-Source Tools and Frameworks for AI Drug Design
inferred← citeshttps://doi.org/10.1007/978-3-032-25187-9_30openalex-snapshot
AI in Healthcare: Disease Detection, Predictive Analytics, Drug Discovery, and Digital Twins for Personalized Medicine
inferred← citeshttps://doi.org/10.1007/978-3-032-25486-3_5openalex-snapshot
AI in Precision Medicine and Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-3-032-40774-0_11openalex-snapshot
Re-evaluating Out-of-Distribution Learning in Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-981-92-0477-9_6openalex-snapshot
Advances in Small-Molecule Inhibitors for Targeted Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-981-95-2300-9_32-1openalex-snapshot
Antifungal Resistance and Development of Fungicidal Agents
inferred← citeshttps://doi.org/10.1007/s00044-026-03547-0openalex-snapshot
Tropanes in natural products, syntheses, and drugs: some insights from the new millennium
inferred← citeshttps://doi.org/10.1007/s00044-026-03616-4openalex-snapshot
Artificial intelligence–assisted lead optimization in drug discovery: bridging computational advances and translational challenges
inferred← citeshttps://doi.org/10.1007/s10787-026-02113-9openalex-snapshot
Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation
inferred← citeshttps://doi.org/10.1007/s10787-026-02193-7openalex-snapshot
Drug repurposing against viral infections (2020–2025): clinical trials, computational strategies, and therapeutic interventions
inferred← citeshttps://doi.org/10.1007/s44272-025-00052-0openalex-snapshot
Advancing cancer care through artificial intelligence: from innovative models to clinical decision-making and regulatory integration
inferred← citeshttps://doi.org/10.1007/s44371-026-00634-4openalex-snapshot
Artificial intelligence and machine learning based discovery of bioisosteres (BIOS) of FDA approved MAO-B inhibitors for the management of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/b978-0-443-15862-9.00002-3openalex-snapshot
Lead Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-15862-9.00003-5openalex-snapshot
Lead Modification
inferred← citeshttps://doi.org/10.1016/b978-0-443-27781-8.00019-1openalex-snapshot
Assessing the global innovation gap in antibiotic development and alternative therapies for combating antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/b978-0-443-33704-8.00014-8openalex-snapshot
Aquaculture drug design using AI and ML methods
inferred← citeshttps://doi.org/10.1016/b978-0-443-40338-5.00006-8openalex-snapshot
AI based target-ligand binding methods
inferred← citeshttps://doi.org/10.1016/b978-0-443-40572-3.00004-6openalex-snapshot
Artificial intelligence in clinical trials: a transformative force
inferred← citeshttps://doi.org/10.1016/b978-0-443-44415-9.00004-1openalex-snapshot
AI-powered In silico ADMET modeling and optimization in drug design
inferred← citeshttps://doi.org/10.1016/b978-0-443-44415-9.00014-4openalex-snapshot
Artificial intelligence in multi-omics integration for precision drug design
inferred← citeshttps://doi.org/10.1016/b978-0-443-44430-2.00011-6openalex-snapshot
Revolutionizing the power of AI's role in precision medicine: Transforming biologics, cell and gene therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-45105-8.00006-8openalex-snapshot
Approaches of computer-aided drug design/artificial intelligence in drug discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-45380-9.00017-1openalex-snapshot
Experimental tools for sirtuin modulation: from CRISPR to chemical biology
inferred← citeshttps://doi.org/10.1016/j.ailsci.2026.100183openalex-snapshot
Artificial intelligence in drug discovery: Integrating data, models, and mechanisms for next-generation therapeutics
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2026.124431openalex-snapshot
AI-driven biomolecular design: Modalities, models, and translation
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.110508openalex-snapshot
AI-guided discovery of a brain-penetrant LILRB4 inhibitor active in microglial and 5xFAD models of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.cellsig.2025.112191openalex-snapshot
Pannexin1: A potential therapeutic target for multi-organ ischemic diseases
inferred← citeshttps://doi.org/10.1016/j.chemphys.2026.113522openalex-snapshot
A machine learning-driven multiscale framework for virtual screening of natural products: Identification of ERK2 inhibitors from the SuperNatural II database
inferred← citeshttps://doi.org/10.1016/j.chmed.2026.05.002openalex-snapshot
From empiricism to precision: SHINE strategy in anti-fibrotic drug discovery
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2026.108906openalex-snapshot
AI-fragmented derivatives of methotrexate to design effective and safer DHFR inhibitor: A computational breakthrough for ectopic pregnancy therapy
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2026.109447openalex-snapshot
Bulk and single-cell transcriptomics identify tumor-specific epithelial PSAT1 as a ferroptosis-associated therapeutic target in cervical cancer
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.111372openalex-snapshot
AI-driven transfer learning and classical molecular dynamics for strategic therapeutic repurposing and rational design of antiviral peptides targeting monkeypox virus DNA polymerase
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2026.111630openalex-snapshot
A decoction-inspired genetic algorithm and PPO reinforcement learning for intelligent molecular discovery: Anti-colorectal cancer candidates from the tiao-pi AnChang formula
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2026.111832openalex-snapshot
Integrating experimental biology, computational methods, and artificial intelligence in anticancer drug discovery: Bridging the translational gap
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104605openalex-snapshot
Democratising real-world drug discovery through agentic AI
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104655openalex-snapshot
Foundation models and AI agents in oncology drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104679openalex-snapshot
Physics-inspired explainable AI for mechanistic and decision support in drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104835openalex-snapshot
From artificial intelligence promise to translational practice in drug discovery: Reproducibility, validation and evidence-based implementation
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.119053openalex-snapshot
Chemical methodologies for Direct-to-Biology library synthesis
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.178686openalex-snapshot
Beyond the cage: The rise and promise of non-animal models in biomedical research
inferred← citeshttps://doi.org/10.1016/j.ejps.2026.107651openalex-snapshot
Artificial intelligence–driven multi-omics analysis reveals hydroxytyrosol targeting of the TXNIP–NLRP3 inflammasome axis in traumatic brain injury
inferred← citeshttps://doi.org/10.1016/j.engappai.2026.115827openalex-snapshot
Generative Artificial Intelligence and Diffusion models in Drug Discovery: A Critical Review
inferred← citeshttps://doi.org/10.1016/j.engappai.2026.115976openalex-snapshot
Transformers in protein informatics: A survey of structure prediction, function annotation, interactions, and drug discovery
inferred← citeshttps://doi.org/10.1016/j.hlpt.2026.101257openalex-snapshot
Architecting an AI-Native drug development ecosystem: Policy lessons from Japan
inferred← citeshttps://doi.org/10.1016/j.ibmed.2025.100316openalex-snapshot
Artificial intelligence for natural product drug discovery and development: current landscape, applications, and future directions
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2026.150138openalex-snapshot
Leveraging complementary functions of hydroxypropyl methylcellulose and croscarmellose sodium to develop gastroretentive tablets via predictive regression-based modeling
inferred← citeshttps://doi.org/10.1016/j.inhs.2026.100087openalex-snapshot
Pharmaceutical quality enhancement: Robotics and automation's role in advancing Good Manufacturing Practices
inferred← citeshttps://doi.org/10.1016/j.iphar.2026.100005openalex-snapshot
AI for theoretical and practical pharmaceutical education: Opportunities, risks and future directions
inferred← citeshttps://doi.org/10.1016/j.jpha.2026.101630openalex-snapshot
Bridging Realms: Artificial Intelligence Integrates Omics, Generative Models, and Traditional Medicine for Anticancer Drug Innovation
inferred← citeshttps://doi.org/10.1016/j.mex.2025.103735openalex-snapshot
TARGETFLOW:An automated literature mining pipeline for accelerating the discovery of high-potential targets in rare and mature diseases
inferred← citeshttps://doi.org/10.1016/j.microc.2025.116360openalex-snapshot
Sustainable extraction: a comprehensive review of advancements beyond conventional methods
inferred← citeshttps://doi.org/10.1016/j.mtadv.2026.100885openalex-snapshot
Stimuli-responsive polymeric nanoparticles and nanocomposites for targeted glioblastoma therapy and diagnosis: recent preclinical progress and translational challenges
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2025.08.055openalex-snapshot
Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer’s diseases
inferred← citeshttps://doi.org/10.1016/j.nxnano.2025.100335openalex-snapshot
Bioinformatics models in drug delivery: Predicting biomaterial-biological interactions for targeted therapies
inferred← citeshttps://doi.org/10.1016/j.premed.2026.100061openalex-snapshot
Artificial intelligence across the drug discovery pipeline: From data integration to precision therapeutics
inferred← citeshttps://doi.org/10.1016/j.pscia.2026.100119openalex-snapshot
Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation
inferred← citeshttps://doi.org/10.1016/j.scijus.2026.101408openalex-snapshot
On-site strip-type drug test kit enhanced by AI-based image analysis
inferred← citeshttps://doi.org/10.1016/j.slasd.2026.100335openalex-snapshot
Decision-grade evidence for AI-enabled small-molecule discovery
inferred← citeshttps://doi.org/10.1021/acs.jafc.5c16967openalex-snapshot
From Genome Inspection to Precision Agrochemicals: A Structure-Based Antivirulence Roadmap for Sustainable Crop Protection against Xylella fastidiosa
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c02826openalex-snapshot
MML-DTI: Multimanifold Learning with Hyperbolic Graph Neural Networks for Enhanced Drug–Target Interaction Prediction
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c00014openalex-snapshot
WeMol: A Cloud-Based and Zero-Code Platform for AI-Driven Molecular Design and Simulation
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c00329openalex-snapshot
AI-MedCraft: A Strategy-Driven AI Platform for Multi-Objective Molecular Design
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c01212openalex-snapshot
MVR-DTI: A Multimodal Molecular Visual Representation Learning for Drug–Target Interaction Prediction
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c03833openalex-snapshot
A Combined Chemoinformatics- and Machine Learning-Based Approach Identifies Chlormidazole as a Drug Repurposing Candidate against Aggressive Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c01822openalex-snapshot
Bridging the Gap between Discovery and Clinical Reality in Radiopharmaceuticals: A Translational Science Perspective on Safety, Efficacy, and Manufacturability
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.5c01998openalex-snapshot
A Review on AI-Based Data-Driven Models for Optimization of Nanocarriers as Drug Delivery Systems
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.6c00187openalex-snapshot
AI-Driven Design and Clinical Translation of Nucleotide−Peptide and Peptide−Drug Conjugates
inferred← citeshttps://doi.org/10.1021/acschemneuro.6c00148openalex-snapshot
Leveraging Advanced AI Frameworks for Dual PPAR α/γ Agonist Discovery in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/acsnanomed.5c00180openalex-snapshot
Quantitative Computational Validation of Nanoscale Interactions between Drug Molecules and Diabetic Wound-Related Proteins for Drug Discovery
inferred← citeshttps://doi.org/10.1021/acsomega.6c00778openalex-snapshot
Integrative In Silico and In Vivo Evidence of Quercetin as a Multitarget Neuroprotective Agent in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/acsomega.6c02849openalex-snapshot
Symphony-Bind: Prediction of Protein Binding Sites for 11 Representative Small Molecules and Ions via Fine-Tuning Protein Language Models and Grouped Multi-Task Learning
inferred← citeshttps://doi.org/10.1021/acsomega.6c04405openalex-snapshot
Data-Driven Approach for Bioreactor Monitoring and Prediction in Monoclonal Antibody Production
inferred← citeshttps://doi.org/10.1038/s41573-026-01496-2openalex-snapshot
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
inferred← citeshttps://doi.org/10.1038/s41598-026-47765-3openalex-snapshot
Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system
inferred← citeshttps://doi.org/10.1038/s44276-026-00221-1openalex-snapshot
Precision oncology in the age of AI: lessons from AI-driven drug discovery and clinical translation
inferred← citeshttps://doi.org/10.1038/s44321-026-00515-4openalex-snapshot
New thinking for the next generation of antimalarials
inferred← citeshttps://doi.org/10.1038/s44386-026-00075-0openalex-snapshot
The rise of agentic AI in drug discovery from static tools to autonomous virtual scientists
inferred← citeshttps://doi.org/10.1039/9781837070206-00280openalex-snapshot
Machine Learning in Predicting the Physicochemical Properties of Drug Candidates
inferred← citeshttps://doi.org/10.1039/d5cc06239jopenalex-snapshot
Protein–DNA interactions in disease and drug discovery
inferred← citeshttps://doi.org/10.1039/d5dd00504copenalex-snapshot
AI-driven natural product-based antiviral drug development: a technical overview
inferred← citeshttps://doi.org/10.1039/d5lc00426hopenalex-snapshot
Organ-on-a-chip: key industry insights, challenges, and opportunities from 100+ NSF I-Corps interviews
inferred← citeshttps://doi.org/10.1039/d5md00672dopenalex-snapshot
Accelerating compound synthesis in drug discovery: the role of digitalisation and automation
inferred← citeshttps://doi.org/10.1039/d6md00319bopenalex-snapshot
Closed-loop agentic AI in drug discovery
inferred← citeshttps://doi.org/10.1039/d6ra02591aopenalex-snapshot
Privileged nitrogen heterocycles in anticancer drug discovery: recent advances on imidazole, indole, and pyrimidine scaffolds
inferred← citeshttps://doi.org/10.1055/a-2810-8972openalex-snapshot
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision
inferred← citeshttps://doi.org/10.1080/03008207.2025.2538562openalex-snapshot
Drug repurposing for osteoarthritis disease modification in the early 21 st century
inferred← citeshttps://doi.org/10.1080/03639045.2026.2649846openalex-snapshot
Generative artificial intelligence and large language models in pharmaceutical formulation and personalized pharmacy: a review of opportunities, technical constraints, and regulatory readiness
inferred← citeshttps://doi.org/10.1080/03639045.2026.2670435openalex-snapshot
A review on artificial intelligence in pharmaceutical sciences: opportunities and challenges
inferred← citeshttps://doi.org/10.1080/10717544.2026.2624192openalex-snapshot
Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions
inferred← citeshttps://doi.org/10.1080/13543784.2026.2616752openalex-snapshot
KIF18A inhibition and its rising role in cancer therapy trials: from bench to bedside
inferred← citeshttps://doi.org/10.1080/17460441.2026.2624023openalex-snapshot
Learning from the successes and failures of early artificial intelligence (AI) adoption for drug discovery in Big BioPharma
inferred← citeshttps://doi.org/10.1080/17460441.2026.2667912openalex-snapshot
Multi-target approaches to prion disease drug discovery: a status update
inferred← citeshttps://doi.org/10.1080/17460441.2026.2712551openalex-snapshot
Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications
inferred← citeshttps://doi.org/10.1080/17460441.2026.2723800openalex-snapshot
Bioengineered In vitro bone marrow models of acute myeloid leukemia for novel drug discovery
inferred← citeshttps://doi.org/10.1080/17568919.2026.2675873openalex-snapshot
Developments in the design and therapeutic applications of GSK3β inhibitors
inferred← citeshttps://doi.org/10.1080/19466315.2026.2656249openalex-snapshot
Statistical Methodology Groups in the Pharmaceutical Industry #
inferred← citeshttps://doi.org/10.1093/bib/bbag245openalex-snapshot
The next paradigm in bioinformatics: a review of multi-agent systems and foundational models for end-to-end scientific discovery
inferred← citeshttps://doi.org/10.1093/bib/bbag392openalex-snapshot
Graph-based drug–target interaction modeling: from representation learning to output-driven drug discovery
inferred← citeshttps://doi.org/10.1101/2025.08.08.669293openalex-snapshot
OptiRanker: an Advanced Tool for Simulation and Comparative Analysis of Drug Prioritization Algorithms in in-Vivo Trials
inferred← citeshttps://doi.org/10.1109/access.2026.3656368openalex-snapshot
Multimodal Vision–Language Models in Medical Imaging: A Survey of Retrieval, Interpretability, and Trust
inferred← citeshttps://doi.org/10.1109/icftic68075.2025.11325062openalex-snapshot
DeepBindPharma: A Multi-Modal Deep Learning Framework with Cross-Attention Integration for Drug-Target Affinity Prediction
inferred← citeshttps://doi.org/10.1109/icicit69063.2026.11633891openalex-snapshot
AI-Integrated Medical Drug Store For Symptom Analysis and Intelligent Drug Recommendation
inferred← citeshttps://doi.org/10.1109/iri66576.2025.00024openalex-snapshot
Accelerating Drug Discovery with Deep Reinforcement Learning: Molecular Generation Using Deep Q-Network
inferred← citeshttps://doi.org/10.1109/nelex69209.2026.11590021openalex-snapshot
Integrated Multi-Omics Modeling for Drug Toxicity and Side-Effect Prediction
inferred← citeshttps://doi.org/10.1109/smart66937.2025.11389598openalex-snapshot
Machine Learning in Drug Discovery and Development
inferred← citeshttps://doi.org/10.1111/bph.70592openalex-snapshot
Artificial intelligence (AI) as a catalyst for mechanistic target discovery: Integrating systems pharmacology and multimodal data
inferred← citeshttps://doi.org/10.1111/soc4.70212openalex-snapshot
New Technology and Work: AI and the Coming Struggle to Democratise Work Organisation
inferred← citeshttps://doi.org/10.1128/msphere.00860-25openalex-snapshot
Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development
inferred← citeshttps://doi.org/10.1134/s1990747826700224openalex-snapshot
Diverse Action of Diazepinobenzimidazole Derivatives on the Glutamatergic Transmission: Structure–Function Study
inferred← citeshttps://doi.org/10.1152/ajpheart.00465.2025openalex-snapshot
Beyond transcription: RNA-binding proteins steering angiogenesis
inferred← citeshttps://doi.org/10.1152/physrev.00045.2025openalex-snapshot
Epithelial plasma membrane transporters as drug targets
inferred← citeshttps://doi.org/10.11648/j.jddmc.20261202.11openalex-snapshot
Machine Learning-Assisted in Silico Identification of Phytoconstituents as Potential NS5 RdRp Inhibitors for Dengue Therapeutics
inferred← citeshttps://doi.org/10.1177/15230864261483982openalex-snapshot
The Ferroptosis–Immunity Axis in Diabetic Kidney Disease: Emerging Therapeutic Targets
inferred← citeshttps://doi.org/10.1186/s12967-025-06856-xopenalex-snapshot
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies
inferred← citeshttps://doi.org/10.1186/s12985-025-02966-6openalex-snapshot
Antiviral candidates for enterovirus 71: targeting viral proteome and stage-specific lifecycle interventions
inferred← citeshttps://doi.org/10.1186/s13321-026-01200-xopenalex-snapshot
Framework for evaluating explainable AI in antimicrobial drug discovery
inferred← citeshttps://doi.org/10.1186/s13321-026-01256-9openalex-snapshot
Multimodal feature fusion for molecular property classification
inferred← citeshttps://doi.org/10.1186/s13321-026-01273-8openalex-snapshot
The impact of reward scalarization and weight scheduling on optimization dynamics in multi-objective molecular design
inferred← citeshttps://doi.org/10.1186/s43094-026-00954-3openalex-snapshot
Navigation of drug discovery via artificial intelligence
inferred← citeshttps://doi.org/10.1186/s43556-026-00498-1openalex-snapshot
Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation
inferred← citeshttps://doi.org/10.13005/ojc/420426openalex-snapshot
Harnessing Artificial Intelligence for Rational Drug Design and Precision Delivery: Bridging Computational Intelligence with Chemical Innovation
inferred← citeshttps://doi.org/10.1371/journal.pone.0356614openalex-snapshot
3D CNN-CVAE and LSTM-guided de novo design of rotigotine derivatives targeting dopamine D1 and D3 receptors in restless legs syndrome
inferred← citeshttps://doi.org/10.14293/pr2199.004365.v1openalex-snapshot
Artificial Intelligence For Drug Discovery
inferred← citeshttps://doi.org/10.18705/2311-4495-2025-12-6-584-591openalex-snapshot
Panasian system for coordination of efforts aiming the translational medicine development. Role and place of the In Silico models
inferred← citeshttps://doi.org/10.20935/acadbiol8077openalex-snapshot
Systems biology approaches for multi omics integration using artificial intelligence
inferred← citeshttps://doi.org/10.21203/rs.3.rs-10867177/v1openalex-snapshot
An integrated in silico and in vitro approach for the identification of potent novel PAD4 inhibitors
inferred← citeshttps://doi.org/10.21203/rs.3.rs-9667555/v1openalex-snapshot
In-Silico Screening and Molecular Dynamics Evaluation of Spirulina Platensis-Derived Compounds as Potential Antiviral Agents Against Dengue Virus NS2b/NS3 Protease
inferred← citeshttps://doi.org/10.2147/dddt.s588295openalex-snapshot
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing
inferred← citeshttps://doi.org/10.21686/2073-1051-2025-4-167-183openalex-snapshot
Artificial Intelligence Systems in Pharmacy
inferred← citeshttps://doi.org/10.24182/2073-6258-2026-25-2-73-83openalex-snapshot
Evolution of innovation management approaches in the R&D of pharmaceutical industry
inferred← citeshttps://doi.org/10.2478/ebtj-2026-0018openalex-snapshot
The Next Fifty Years: Drug Discovery in the Age of the Computational Self
inferred← citeshttps://doi.org/10.31127/tuje.1872054openalex-snapshot
Engineering Intelligence for Drug Discovery: Atomica as an AI-Powered Computational Platform for Real-Time Molecular Design and Bioactivity Analysis
inferred← citeshttps://doi.org/10.3389/ebm.2026.10988openalex-snapshot
Training the next-generation of biomedical scientists through artificial intelligence-driven education and research in pharmacology and pharmaceutical sciences
inferred← citeshttps://doi.org/10.3389/fddsv.2025.1731262openalex-snapshot
Enhancing structure-based virtual screening of MDM2–p53 inhibitors: a benchmark of machine learning vs. traditional docking scoring functions
inferred← citeshttps://doi.org/10.3389/fphar.2026.1927954openalex-snapshot
Artificial intelligence-driven drug discovery: a deep learning paradigm shift in pharmaceutical research and development
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1711344openalex-snapshot
From pandemics to preparedness: harnessing AI, CRISPR, and synthetic biology to counter biosecurity threats
inferred← citeshttps://doi.org/10.3390/antibiotics15020233openalex-snapshot
Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and Clinical Translation
inferred← citeshttps://doi.org/10.3390/bioengineering12121315openalex-snapshot
Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review
inferred← citeshttps://doi.org/10.3390/biom15091303openalex-snapshot
Natural Product-Derived Drugs: Structural Insights into Their Biological Mechanisms
inferred← citeshttps://doi.org/10.3390/biom16030410openalex-snapshot
Licochalcone A as a Potential Anti-Toxoplasma Agent: A Target Identification and Pharmacokinetic Study
inferred← citeshttps://doi.org/10.3390/biomedinformatics6040054openalex-snapshot
In Silico Characterization of the Venom-Derived LW-9 Peptide Using PreADMET-Based Predictions
inferred← citeshttps://doi.org/10.3390/cimb48090922openalex-snapshot
Cross-Species Triage of SERT-Oriented Polyheteroaryl Candidates Prioritizes AD20/UtIA-0108 as an Early Neuroactive Candidate
inferred← citeshttps://doi.org/10.3390/foods15132349openalex-snapshot
Food-Derived Multi-Target Antihypertensive Peptides: Sources, Mechanisms and AI-Driven Strategies
inferred← citeshttps://doi.org/10.3390/ijms27167497openalex-snapshot
Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery
inferred← citeshttps://doi.org/10.3390/life16081328openalex-snapshot
Semaphorins and Their Role in Neuropathic Pain
inferred← citeshttps://doi.org/10.3390/md24060199openalex-snapshot
Effect of Algal Lectin Siye on Proliferation and Apoptosis of Breast and Colon Cancer Cells
inferred← citeshttps://doi.org/10.3390/medsci14020248openalex-snapshot
Artificial Intelligence Across the Drug Development Lifecycle
inferred← citeshttps://doi.org/10.3390/microorganisms14010255openalex-snapshot
The Tumor Cell Proliferation Inhibitory Activity of the Human Herpes Virus Type 6 U94 Protein Relies on a Stable Tridimensional Conformation
inferred← citeshttps://doi.org/10.3390/ph18081176openalex-snapshot
Network Pharmacology and Machine Learning Identify Flavonoids as Potential Senotherapeutics
inferred← citeshttps://doi.org/10.3390/ph18101536openalex-snapshot
From AI-Assisted In Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery
inferred← citeshttps://doi.org/10.3390/ph18121793openalex-snapshot
Advancing PROTAC Discovery Through Artificial Intelligence: Opportunities, Challenges, and Future Directions
inferred← citeshttps://doi.org/10.3390/ph19050696openalex-snapshot
From Algorithms to Assets: A Comprehensive Review of AI’s Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation
inferred← citeshttps://doi.org/10.3390/ph19060810openalex-snapshot
Harnessing Machine Learning for Accelerated Drug Discovery: Opportunities and Unmet Challenges
inferred← citeshttps://doi.org/10.3390/ph19060878openalex-snapshot
Machine Learning-Aided Drug Repurposing for Screening COX-2 Inhibitors from Traditional Chinese Medicines
inferred← citeshttps://doi.org/10.3390/ph19081248openalex-snapshot
Chemical Scaffolds Driving Modern Anticancer Drug Discovery and Radiotheranostics: Structural Determinants, Translational Opportunities and Future Perspectives
inferred← citeshttps://doi.org/10.3390/sci7040179openalex-snapshot
A Review of Artificial Intelligence (AI)-Driven Smart and Sustainable Drug Delivery Systems: A Dual-Framework Roadmap for the Next Pharmaceutical Paradigm
inferred← citeshttps://doi.org/10.34133/csbj.0144openalex-snapshot
Beyond Random Splits: Assessing the Generalization of Graph and Vector Models for WT-Structure-Only Drug Resistance Prediction under Protein-Disjoint Evaluation
inferred← citeshttps://doi.org/10.37648/ijps.v21i04.011openalex-snapshot
Artificial Intelligence in Life Sciences: Considerations for Policy-Making and Social Impact
inferred← citeshttps://doi.org/10.37827/ntsh.chem.2025.78.007openalex-snapshot
GLOBAL MARKET FOR ARTIFICIAL INTELLIGENCE IN THE CHEMICAL INDUSTRY
inferred← citeshttps://doi.org/10.38124/ijisrt/25sep789openalex-snapshot
Steric Modulation of Aromatic Compounds via Friedel–Craft Alkylation for Potential Reduction in Blood-Brain Barrier Permeability
inferred← citeshttps://doi.org/10.4018/979-8-3373-5258-9.ch008openalex-snapshot
Artificial Intelligence in Clinical Trials of Drugs
inferred← citeshttps://doi.org/10.4103/ejpi.ejpi-d-25-00069openalex-snapshot
Deep Learning Technology in Genomics, Radiotherapy, and Ophthalmology for Precision Medicine
inferred← citeshttps://doi.org/10.4103/ipj.ipj_383_25openalex-snapshot
Novel biomarkers for treatment response prediction: New fix or mere optics
inferred← citeshttps://doi.org/10.4103/njsoma.njsoma_19_26openalex-snapshot
Artificial Intelligence in Biomedical Research: From AI Tools to AI Mega Agents in a Human-in-Charge Framework
inferred← citeshttps://doi.org/10.4236/ajibm.2025.1510077openalex-snapshot
Trends Shaping the World of the Pharmaceutical Market
inferred← citeshttps://doi.org/10.52711/0975-4377.2026.00021openalex-snapshot
AI and the Future of Pharmacy: Innovation, Ethics, and Impact
inferred← citeshttps://doi.org/10.52927/jdcr.2025.13.2.168openalex-snapshot
Construction and Application of Patient-derived Organoid Models for Gastrointestinal Cancer Precision Therapy
inferred← citeshttps://doi.org/10.53365/nrfhh/217344openalex-snapshot
Integrating Artificial Intelligence and Machine Learning in Natural Product Discovery: From Omics Data to Drug Design
inferred← citeshttps://doi.org/10.55813/gaea/rcym/v4/n4/267openalex-snapshot
Inteligencia artificial en I+D farmacéutica: innovación en descubrimiento de fármacos y ensayos clínicos
inferred← citeshttps://doi.org/10.58920/sciphar0501543openalex-snapshot
Leveraging Artificial Intelligence to Strengthen Vaccine and Drug Development Capacity in Low-resource African Settings
inferred← citeshttps://doi.org/10.64187/mm.2026.v2.i2.007openalex-snapshot
Challenges and Emerging Strategies in Marine Natural Product Discovery and Drug Development
inferred← citeshttps://doi.org/10.64595/jmpb.122026.730openalex-snapshot
Studi In Silico Toxicity Stress Response Pathways dan Toxicity Targets Obat Amoxicillin Menggunakan Pendekatan Komputasi
inferred← citeshttps://doi.org/10.64595/jmpb.122026.737openalex-snapshot
Analisis Komputasi untuk Memprediksi Organ Toxicity dan Toxicity End Points pada Penggunaan Paracetamol
inferred← citeshttps://doi.org/10.64898/2026.06.12.731845openalex-snapshot
AI-Guided Discovery of Small Molecule LILRB4 (ILT3) Inhibitors Reprograms Microglia and Reduces Amyloid Pathology
inferred← citeshttps://doi.org/10.65249/1027-7218-2026-3-68-80openalex-snapshot
Artificial intelligence technologies in healthcare: current state, risks, and future
inferred← citeshttps://doi.org/10.70315/uloap.ulbec.2026.0303001openalex-snapshot
Impact of No-Code AI Drug Discovery Platforms on the Operational Cost Structure of Biotechnology Ventures
inferred← citeshttps://doi.org/10.7717/peerj.20541openalex-snapshot
AI-driven de novo design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.